Literature DB >> 19155270

Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies.

M R Ackroyd1, L Skordis, M Kaluarachchi, J Godwin, S Prior, M Fidanboylu, R J Piercy, F Muntoni, S C Brown.   

Abstract

Mutations in fukutin related protein (FKRP) are responsible for a common group of muscular dystrophies ranging from adult onset limb girdle muscular dystrophies to severe congenital forms with associated structural brain involvement, including Muscle Eye Brain disease. A common feature of these disorders is the variable reduction in the glycosylation of skeletal muscle alpha-dystroglycan. In order to gain insight into the pathogenesis and clinical variability, we have generated two lines of mice, the first containing a missense mutation and a neomycin cassette, FKRP-Neo(Tyr307Asn) and the second containing the FKRP(Tyr307Asn) mutation alone. We have previously associated this missense mutation with a severe muscle-eye-brain phenotype in several families. Homozygote Fkrp-Neo(Tyr307Asn) mice die soon after birth and show a reduction in the laminin-binding epitope of alpha-dystroglycan in muscle, eye and brain, and have reduced levels of FKRP transcript. Homozygous Fkrp(Tyr307Asn) mice showed no discernible phenotype up to 6 months of age, contrary to the severe clinical course observed in patients with the same mutation. These results suggest the generation of a mouse model for FKRP related muscular dystrophy requires a knock-down rather than a knock-in strategy in order to give rise to a disease phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155270     DOI: 10.1093/brain/awn335

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  26 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

3.  Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.

Authors:  Huaiyu Hu; Jing Li; Zhen Zhang; Miao Yu
Journal:  Neurosci Lett       Date:  2010-12-01       Impact factor: 3.046

4.  Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Authors:  Chi-Hsien Wang; Yiumo Michael Chan; Ru-Hang Tang; Bin Xiao; Peijuan Lu; Elizabeth Keramaris-Vrantsis; Hui Zheng; Chunping Qiao; Jiangang Jiang; Juan Li; Hsin-I Ma; Qilong Lu; Xiao Xiao
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies.

Authors:  Vandana Gupta; Genri Kawahara; Stacey R Gundry; Aye T Chen; Wayne I Lencer; Yi Zhou; Leonard I Zon; Louis M Kunkel; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

6.  Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes.

Authors:  Anthony Blaeser; Elizabeth Keramaris; Yiumo M Chan; Susan Sparks; Dale Cowley; Xiao Xiao; Qi Long Lu
Journal:  Hum Genet       Date:  2013-04-17       Impact factor: 4.132

7.  Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.

Authors:  Aaron M Beedle; Amy J Turner; Yoshiaki Saito; John D Lueck; Steven J Foltz; Marisa J Fortunato; Patricia M Nienaber; Kevin P Campbell
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

8.  212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015.

Authors:  M Saunier; C G Bönnemann; M Durbeej; V Allamand
Journal:  Neuromuscul Disord       Date:  2016-02-15       Impact factor: 4.296

9.  Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain.

Authors:  Jakob S Satz; Adam P Ostendorf; Shangwei Hou; Amy Turner; Hajime Kusano; Jane C Lee; Rolf Turk; Huy Nguyen; Susan E Ross-Barta; Steve Westra; Toshinori Hoshi; Steven A Moore; Kevin P Campbell
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

10.  Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy.

Authors:  Helen S Booler; Josie L Williams; Mark Hopkinson; Susan C Brown
Journal:  Brain Pathol       Date:  2015-10-12       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.